期刊文献+

健康人鼻咽部表面活性物质的测定 被引量:3

Measurement of the surfactant in irrigating fluid from nasopharynx in healthy persons
下载PDF
导出
摘要 目的探讨健康人鼻咽部表面活性物质的状况,并对磷脂成分进行研究。方法采集健康人鼻咽部灌洗液,用高效液相色谱方法对表面活性物质的磷脂酰丝氨酸、磷脂酰乙胺醇、磷脂酰胆碱和鞘磷脂进行测定。结果①鼻咽部存在表面活性物质,磷脂4种成分均可测出;②磷脂成分的构成中,磷脂酰胆碱含量最多,为(53.94±17.10)%,是主要成分,其次是鞘磷脂和磷脂酰丝氨酸,分别是(22.18±24.08)%和(17.58±9.03)%,磷脂酰乙醇胺只占小部分,为(6.30±4.28)%。结论①鼻咽部存在表面活性物质;②鼻咽部表面活性物质的磷脂由磷脂酰丝氨酸、磷脂酰乙胺醇、磷脂酰胆碱和鞘磷脂组成,磷脂酰胆碱含量最多,对鼻咽部表面活性物质起决定作用。 OBJECTIVE To investigate the situation of nasopharyngeal surfactant in healthy persons, and to study biochemical component of phospholipid of surface active substance. METHODS The concentrations of surfactant in nasopharyngeal irrigating fluid were implemented in healthy persons. Component of phospholipid such as phosphatidylsedne, phosphatidyl ethanolamine, phosphatidylcholine and sphingophospholipid were measured by the highperformance liquid chromatograph. RESULTS (1) There was surfactant in nasopharynx. Four compositions of phospholipid could be measured; (2) In composition of phospholipid, the percentages of phosphatidylcholine , sphingophospholipid, phosphatidylserine and phosphatidyl ethanolamine were (53.94±17.10) %, (22.18±24.08) %, (17.58±9.03) % and (6.30 ±4.28) % respectively. CONCLUSION (1) There is surfactant in nasopharynx; (2)Nasopharyngeal surfactant is made of phosphatidylcholine, sphingophospholipid, phosphatidylserine and phosphatidyl ethanolamine.
出处 《中国耳鼻咽喉头颈外科》 北大核心 2007年第3期169-171,共3页 Chinese Archives of Otolaryngology-Head and Neck Surgery
基金 广州市卫生局医药卫生科技项目基金资助
关键词 磷脂类 表面活性剂 鼻咽 Phospholipids Surface-Active Agent Nasopharynx
  • 相关文献

参考文献8

二级参考文献5

共引文献88

同被引文献25

  • 1杨伟炎,王荣光,孙建和,候宁,朱光明,张曙光.咽鼓管粘膜分泌细胞与表面活性物质样板层体的观察[J].中华耳鼻咽喉科杂志,1995,30(4):224-226. 被引量:52
  • 2冯立宁,姜斌,陈文弦,刘智广,张晓楠,苟琳.豚鼠咽鼓管和肺脏表面活性物质中磷脂成分的比较[J].第四军医大学学报,1996,17(4):251-253. 被引量:12
  • 3吉晓滨,王群芳,谢景华,杨凯.慢性鼻窦炎患者鼻咽部表面活性物质磷脂构成的测定[J].临床耳鼻咽喉头颈外科杂志,2007,21(2):63-66. 被引量:5
  • 4吉晓滨,柳息洪,王磊.咽鼓管咽口黏膜上皮的超微结构[J].中华耳科学杂志,2007,5(2):164-167. 被引量:3
  • 5[4]Ali MY Histology of the human nasopharyngeal mucosa.J Anat,1965Jul;99(Pt 3):657-672.
  • 6[5]Kiroglu M,Tap O,Mete UO,et al.Ultrastructure of the nasopharyngeal orifice epithelium of the eustachian tube in otitis media with effusion.J Submicrosc Cytol Pathol,1997,29(1):79-84.
  • 7[7]Lin HS,Lin CS,Yeh S,et al.Fine structure of nasopharyngeal carcinoma with special reference to the anaplastie type.Cancer,1969,23(2):390-405.
  • 8[8]Tomoda K,Morii S,Yamashita T,et al.Histologic architecture of submucosal connective tissues in human eustachian tube with supplemental reference to the effects of aging.Arch Otorhinolaryngol,1981,232(1):57-63.
  • 9国家食品药品监督管理局.化学药物临床药代动力学研究技术指导原则[S].2005.
  • 10Buchman CA, Doyle WJ, Swarts JD, et al. Effects of nasal obstruction on Eustachian tube function and middle ear pres- sure[J ]. Acta Otolaryngol, 1999,30 (Stockh) : 193.

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部